Skip to Content

Tag: no-body component


Also Noted

Senseonics initiates first-in-human study of CGM with no-body component

October 27, 2026HME News Staff

GERMANTOWN, Md. – Senseonics has initiated its first-in-human clinical study evaluating Freedom, an investigational next-generation continuous glucose monitor (CGM) system designed to communicate directly with a mobile device without the need for an external on-body transmitter. The company says the Freedom is an evolution of the same fundamental sensing technology as the Eversense 365 system, with the addition of an integrated battery and embedded Bluetooth communication capability. "Now...

Continuous Glucose Monitor (CGM), diabetes management, Freedom, no-body component, Senseonics


Read Full Articlered right arrow icon